Business
RAD to meet with US FDA to align on RAD 101 Phase 3 Trial
RAD to meet with US FDA to align on RAD 101 Phase 3 Trial
About this update from Radiopharm Theranostics Limited
Radiopharm Theranostics Limited has released a press release. View Attachment
View stock analysis, news, and events for Radiopharm Theranostics Limited
More from Radiopharm Theranostics Limited
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Tria...
September 14, 2026
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
September 9, 2026